| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |